Cita APA

Shin, J. W., Kim, S., Ha, S., Choi, B., Kim, S., Im, S., . . . Chung, J. (2019). The HER2 S310F Mutant Can Form an Active Heterodimer with the EGFR, Which Can Be Inhibited by Cetuximab but Not by Trastuzumab as well as Pertuzumab. Biomolecules.

Chicago Style Citation

Shin, Jung Won, Soohyun Kim, Suji Ha, Byungsan Choi, Seongyeong Kim, Seock-Ah Im, Tae-Young Yoon, i Junho Chung. "The HER2 S310F Mutant Can Form an Active Heterodimer With the EGFR, Which Can Be Inhibited By Cetuximab but Not By Trastuzumab As Well As Pertuzumab." Biomolecules 2019.

Cita MLA

Shin, Jung Won, et al. "The HER2 S310F Mutant Can Form an Active Heterodimer With the EGFR, Which Can Be Inhibited By Cetuximab but Not By Trastuzumab As Well As Pertuzumab." Biomolecules 2019.